Contract Research
Invenra Inc., an innovative leader in bispecific antibody technology, is pleased to announce a strategic collaboration with Catalent, a global Contract Dev...
April 03, 2024 | News
Resonance Health Ltd, listed on the Australian Securities Exchange (ASX) under the ticker RHT, has officially announced its strategic move into the Japanes...
March 28, 2024 | News
Aragen, a leading Contract Research Development and Manufacturing Organization (CRDMO) for small molecules and biologics, announced that it has operat...
March 28, 2024 | News
BioDuro-Sundia's partner, DigmBio, a South Korean biotechnology company, announced its selective PARP1 inhibitor for the treatment of triple-negative breas...
March 26, 2024 | News
WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced ...
March 19, 2024 | News
CDP runs the global disclosure system for investors, companies, cities, states and regions to manage their environmental impact. In 2023, more than...
March 06, 2024 | News
Medidata, a Dassault Systèmes subsidiary and a leading provider of clinical trial solutions for the life sciences industry, today announced a ...
February 29, 2024 | News
RSSL’s Innovation Hub will be a supportive ecosystem for early-stage biotech companies, providing a wide range of tailored services to help t...
February 22, 2024 | News
First manufacturing run successful for MFG7 facility at the Ireland site Largest manufacturing scale to date achieved by combining four 4,000-liter sing...
February 01, 2024 | News
WuXi XDC will provide a fully integrated, one-stop bioconjugate platform and end-to-end CRDMO services. As WuXi XDC's strategic partner, Multitude Therapeu...
January 31, 2024 | News
These were from a relative bioavailability study of nanocrystalline-enabled enzalutamide (nanoenzalutamide) tablet formulation, an alternative to the amorp...
January 29, 2024 | News
Catalent, Inc. the leader in enabling the development and supply of better treatments for patients worldwide, announced its targets to reduce greenho...
January 26, 2024 | News
Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its off-the-shelf Rep/Cap plasmid offering, designed to streamline...
January 17, 2024 | News
Through this strategic acquisition, ClinChoice further broadens its global footprint and full-service capabilities in more than 30 countries throughout&nbs...
January 12, 2024 | News
Most Read
Bio Jobs
News